Jason R. Brown, MD

Drs. Gupta and Brown share their thoughts on the next steps that can aid in uptake of maintenance therapy in different tumor types.

Two oncologists highlight practical considerations when choosing maintenance therapy.

Drs. Brown and Gupta discuss key takeaways from the study and the impact these data are likely to have on clinical practice.

Shilpa Gupta, MD and Jason Brown, MD discuss trials with successful or negative results with maintenance therapy.

Drs. Gupta and Brown review a recently published paper by Grivas et al. (2019) on the use of checkpoint inhibitors for maintenance therapy to prolong the benefits of frontline therapy while minimizing toxicity in solid tumors.